PBRM1 and nonpapillary renal cell carcinoma: Recently, 9p21.3 deletion was reported as an unfavorable factor for immunotherapy responsive in CD8+ T infiltrated ccRCC, whereas PBRM1 mutation was a favorable factor in non-infiltrated ccRCC (10).